View in EDS HTML Full Text PDF Full Text

Physiologically Based Pharmacokinetic Modeling and Simulation to Support a Change in the FDA-Labeled Dosing Frequency of RHB-105 Low-Dose Rifabutin Triple Therapy for Helicobacter pylori Eradication.

Saved in:
Bibliographic Details
Title: Physiologically Based Pharmacokinetic Modeling and Simulation to Support a Change in the FDA-Labeled Dosing Frequency of RHB-105 Low-Dose Rifabutin Triple Therapy for Helicobacter pylori Eradication.
Authors: Vakil N; School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA., Howden CW; College of Medicine, University of Tennessee, Memphis, TN, USA., Shah SC; Division of Gastroenterology, University of California, San Diego, CA, USA., Chen KF; Certara, Simcyp Division, Sheffield, UK., Offman E; Certara, Integrated Drug Development, Montreal, Quebec, Canada., Almenoff JS; RedHill Biopharma, Medical Affairs, Raleigh, NC, USA., Sheldon KL; RedHill Biopharma, Medical Affairs, Raleigh, NC, USA.
Source: Journal of clinical pharmacology [J Clin Pharmacol] 2025 Jun; Vol. 65 (6), pp. 779-786. Date of Electronic Publication: 2025 Jan 02.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley Country of Publication: England NLM ID: 0366372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-4604 (Electronic) Linking ISSN: 00912700 NLM ISO Abbreviation: J Clin Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39745109
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Physiologically Based Pharmacokinetic Modeling and Simulation to Support a Change in the FDA-Labeled Dosing Frequency of RHB-105 Low-Dose Rifabutin Triple Therapy for Helicobacter pylori Eradication.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Vakil+N%22">Vakil N</searchLink>; School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA.<br /><searchLink fieldCode="AU" term="%22Howden+CW%22">Howden CW</searchLink>; College of Medicine, University of Tennessee, Memphis, TN, USA.<br /><searchLink fieldCode="AU" term="%22Shah+SC%22">Shah SC</searchLink>; Division of Gastroenterology, University of California, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Chen+KF%22">Chen KF</searchLink>; Certara, Simcyp Division, Sheffield, UK.<br /><searchLink fieldCode="AU" term="%22Offman+E%22">Offman E</searchLink>; Certara, Integrated Drug Development, Montreal, Quebec, Canada.<br /><searchLink fieldCode="AU" term="%22Almenoff+JS%22">Almenoff JS</searchLink>; RedHill Biopharma, Medical Affairs, Raleigh, NC, USA.<br /><searchLink fieldCode="AU" term="%22Sheldon+KL%22">Sheldon KL</searchLink>; RedHill Biopharma, Medical Affairs, Raleigh, NC, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220366372%22">Journal of clinical pharmacology</searchLink> [J Clin Pharmacol] 2025 Jun; Vol. 65 (6), pp. 779-786. <i>Date of Electronic Publication: </i>2025 Jan 02.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0366372 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1552-4604 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200912700%22">00912700 </searchLink><i>NLM ISO Abbreviation: </i>J Clin Pharmacol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39745109
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/jcph.6178
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 779
    Titles:
      – TitleFull: Physiologically Based Pharmacokinetic Modeling and Simulation to Support a Change in the FDA-Labeled Dosing Frequency of RHB-105 Low-Dose Rifabutin Triple Therapy for Helicobacter pylori Eradication.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Vakil N
      – PersonEntity:
          Name:
            NameFull: Howden CW
      – PersonEntity:
          Name:
            NameFull: Shah SC
      – PersonEntity:
          Name:
            NameFull: Chen KF
      – PersonEntity:
          Name:
            NameFull: Offman E
      – PersonEntity:
          Name:
            NameFull: Almenoff JS
      – PersonEntity:
          Name:
            NameFull: Sheldon KL
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2025 Jun
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1552-4604
          Numbering:
            – Type: volume
              Value: 65
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Journal of clinical pharmacology
              Type: main
ResultId 1